Immunocore Holdings plc (FRA:6YG)
Germany flag Germany · Delayed Price · Currency is EUR
25.00
-0.80 (-3.10%)
At close: Mar 27, 2026

Immunocore Holdings Revenue

In the year 2025, Immunocore Holdings had annual revenue of $400.02M USD with 28.95% growth. Immunocore Holdings had revenue of $104.48M in the quarter ending December 31, 2025, with 24.30% growth.

Revenue
$400.02M
Revenue Growth
+28.95%
P/S Ratio
3.80
Revenue / Employee
$763.39K
Employees
524
Market Cap
1.30B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025400.02M89.81M28.95%
Dec 31, 2024310.20M60.77M24.37%
Dec 31, 2023249.43M75.07M43.05%
Dec 31, 2022174.36M137.88M377.91%
Dec 31, 202136.48M-4.63M-11.26%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Biotest Aktiengesellschaft635.20M
2invest AG28.07M
Darwin AG27.35M
Paion AG14.81M
co.don AG6.24M
MagForce AG1.08M
Biomark Diagnostics57.01K
bioXXmed AG20.49K
Revenue Rankings